Skip to content

Author

S. Dang

We have 3 of 119 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Conference Open access 2026

Exploring naringenin-clozapine combination for synergistic antipsychotic action: An in-silico study

The Clozapine - Naringenin drug combination is a promising multi-target molecule that exhibits excellent oral and overall drug-likeness but has restricted blood-brain barrier penetration with considerable inhibition of CYP enzymes; this indicates possible PK interactions.

Nikita Arora, P. Gauba, S. Dang · 0 citations
2026

In silico evaluation of phytocompounds targeting drug resistance mechanisms in triple-negative breast cancer: Insights from GEO dataset analysis

It is suggested that kirenol, artesunate, apigenin, daidzein, and sclareol have the potential to target specific genes involved in chemoresistance in TNBC and can serve as therapeutic options against drug-resistant TNBC.

R. Raj, S. Dang, R. Gabrani · 0 citations
Review Jul 2026

Nanotechnology-based Approaches for Nose -to- Brain Delivery of Antipsychotics

Insight is provided into how different nano-carrier-based formulations, such as polymeric-based nanoparticles, nano-lipid carriers, nano-emulsions, and solid lipid nanocarriers, enhance drug bioavailability, target affinity, and overcome first-pass metabolism, and also highlights the recent advancements and formulation...

Nikita Arora, S. Dang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.